136 related articles for article (PubMed ID: 26542666)
1. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
Thompson PD; Myerburg RJ; Levine BD; Udelson JE; Kovacs RJ
J Am Coll Cardiol; 2015 Dec; 66(21):2406-2411. PubMed ID: 26542666
[No Abstract] [Full Text] [Related]
2. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Gerhard-Herman MD; Gornik HL; Barrett C; Barshes NR; Corriere MA; Drachman DE; Fleisher LA; Fowkes FG; Hamburg NM; Kinlay S; Lookstein R; Misra S; Mureebe L; Olin JW; Patel RA; Regensteiner JG; Schanzer A; Shishehbor MH; Stewart KJ; Treat-Jacobson D; Walsh ME
Circulation; 2017 Mar; 135(12):e726-e779. PubMed ID: 27840333
[TBL] [Abstract][Full Text] [Related]
3. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett DK; Blumenthal RS; Albert MA; Buroker AB; Goldberger ZD; Hahn EJ; Himmelfarb CD; Khera A; Lloyd-Jones D; McEvoy JW; Michos ED; Miedema MD; Muñoz D; Smith SC; Virani SS; Williams KA; Yeboah J; Ziaeian B
Circulation; 2019 Sep; 140(11):e596-e646. PubMed ID: 30879355
[No Abstract] [Full Text] [Related]
4. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett DK; Blumenthal RS; Albert MA; Buroker AB; Goldberger ZD; Hahn EJ; Himmelfarb CD; Khera A; Lloyd-Jones D; McEvoy JW; Michos ED; Miedema MD; Muñoz D; Smith SC; Virani SS; Williams KA; Yeboah J; Ziaeian B
Circulation; 2019 Sep; 140(11):e563-e595. PubMed ID: 30879339
[TBL] [Abstract][Full Text] [Related]
5. Guidelines in review: Comparison of ESC and ACC/AHA guidelines for the diagnosis and management of patients with stable coronary artery disease.
Joseph J; Velasco A; Hage FG; Reyes E
J Nucl Cardiol; 2018 Apr; 25(2):509-515. PubMed ID: 28884447
[TBL] [Abstract][Full Text] [Related]
6. Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Halperin JL; Levine GN; Al-Khatib SM; Birtcher KK; Bozkurt B; Brindis RG; Cigarroa JE; Curtis LH; Fleisher LA; Gentile F; Gidding S; Hlatky MA; Ikonomidis J; Joglar J; Pressler SJ; Wijeysundera DN
Circulation; 2016 Apr; 133(14):1426-8. PubMed ID: 26399660
[No Abstract] [Full Text] [Related]
7. AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services.
Arnett DK; Goodman RA; Halperin JL; Anderson JL; Parekh AK; Zoghbi WA
Circulation; 2014 Oct; 130(18):1662-7. PubMed ID: 25212466
[No Abstract] [Full Text] [Related]
8. 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization).
Dehmer GJ; Badhwar V; Bermudez EA; Cleveland JC; Cohen MG; D'Agostino RS; Ferguson TB; Hendel RC; Isler ML; Jacobs JP; Jneid H; Katz AS; Maddox TM; Shahian DM
J Am Coll Cardiol; 2020 Apr; 75(16):1975-2088. PubMed ID: 32217040
[No Abstract] [Full Text] [Related]
9. Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.
Fleg JL; Forman DE; Berra K; Bittner V; Blumenthal JA; Chen MA; Cheng S; Kitzman DW; Maurer MS; Rich MW; Shen WK; Williams MA; Zieman SJ;
Circulation; 2013 Nov; 128(22):2422-46. PubMed ID: 24166575
[No Abstract] [Full Text] [Related]
10. 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
; Bozkurt B; Das SR; Addison D; Gupta A; Jneid H; Khan SS; Koromia GA; Kulkarni PA; LaPoint K; Lewis EF; Michos ED; Peterson PN; Turagam MK; Wang TY; Yancy CW
J Am Coll Cardiol; 2022 Jul; 80(4):388-465. PubMed ID: 35753858
[No Abstract] [Full Text] [Related]
11. ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing).
Gibbons RJ; Balady GJ; Beasley JW; Bricker JT; Duvernoy WF; Froelicher VF; Mark DB; Marwick TH; McCallister BD; Thompson PD; Winters WL; Yanowitz FG; Ritchie JL; Cheitlin MD; Eagle KA; Gardner TJ; Garson A; Lewis RP; O'Rourke RA; Ryan TJ
Circulation; 1997 Jul; 96(1):345-54. PubMed ID: 9236456
[No Abstract] [Full Text] [Related]
12. Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association.
McSweeney JC; Rosenfeld AG; Abel WM; Braun LT; Burke LE; Daugherty SL; Fletcher GF; Gulati M; Mehta LS; Pettey C; Reckelhoff JF;
Circulation; 2016 Mar; 133(13):1302-31. PubMed ID: 26927362
[No Abstract] [Full Text] [Related]
13. Comparison of ESC and ACC/AHA guidelines for the diagnosis and management of patients with stable coronary heart disease: Are the differences clinically relevant? An American perspective.
Gibbons RJ
J Nucl Cardiol; 2018 Apr; 25(2):516-520. PubMed ID: 29150751
[No Abstract] [Full Text] [Related]
14. ACC/AHA Guideline for the Management of Patients With Chronic Coronary Disease.
Ebell MH
Am Fam Physician; 2024 Mar; 109(3):Online. PubMed ID: 38574227
[No Abstract] [Full Text] [Related]
15. The 2014 AHA/ACC valve disease guideline: new stages of disease, new treatment options, and a call for earlier intervention.
Mascherbauer J
Wien Klin Wochenschr; 2014 Aug; 126(15-16):458-9. PubMed ID: 25123144
[No Abstract] [Full Text] [Related]
16. Environmental Exposures and Pediatric Cardiology: A Scientific Statement From the American Heart Association.
Zachariah JP; Jone PN; Agbaje AO; Ryan HH; Trasande L; Perng W; Farzan SF;
Circulation; 2024 May; 149(20):e1165-e1175. PubMed ID: 38618723
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant screening for coronary artery disease: data are required before practice change.
Gill JS; Chadban SJ
Kidney Int; 2024 Mar; 105(3):470-472. PubMed ID: 37914085
[TBL] [Abstract][Full Text] [Related]
18. Predicting Cardiovascular Health in Coronary Artery Risk Development in Young Adults.
Gooding HC; Ning H; Gillman MW; Allen N; Goff DC; Rana JS; Chiuve S; Lloyd-Jones DM
J Am Coll Cardiol; 2018 Jun; 71(22):2601-2602. PubMed ID: 29852983
[No Abstract] [Full Text] [Related]
19. What is new in the 2023 AHA/ACC multisociety guideline on chronic coronary disease?
Gragnano F; De Sio V; Calabrò P
Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):673-678. PubMed ID: 37723607
[No Abstract] [Full Text] [Related]
20. Coronary atherosclerosis in athletes: recent insights and clinical considerations.
Aengevaeren VL; Claessen G; Eijsvogels TM
Br J Sports Med; 2024 May; 58(11):574-576. PubMed ID: 38503469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
